Analogic key facts
as of Oct 2026- Developer of healthcare and security technology designed for clinical testing.
- Analogic is valued at approximately $1.1B as of Oct 2026 (last reported valuation).
- It has raised $39.3M; the latest was PE Growth/Expansion in Aug 2025.
- Notable investors include Virginia Innovation Partnership Corporation, The Carlyle Group, Altaris.
- Status: Privately Held (backing).
Analogic's last reported valuation, Jun 2018. Nothing priced has surfaced since.
- ·Watch Analogic: the Monday email on marks, rounds and moves
Analogic funding rounds
No funding rounds for Analogic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Analogic
3Analogic valuation
Analogic's last reported valuation was $1.1 billion in Jun 2018. No priced round, secondary trade or fund mark has surfaced since.
Analogic investors
3 investors are on record for Analogic, including Virginia Innovation Partnership Corporation, The Carlyle Group and Altaris.
About Analogic
Developer of healthcare and security technology designed for clinical testing. The company offers advanced imaging and real-time guidance technologies used for disease diagnosis and treatment, as well as for automated threat detection, thereby improving health and enhancing the safety of people around the world.
- Sector
- Healthcare
- HQ
- Peabody, MA, United States
- Founded
- 1967
- Employees
- 900
- Website
- analogic.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.